Severe mpox among people living with advanced HIV receiving prolonged tecovirimat in New York City
Abstract
Severe mpox has been observed in people with advanced HIV. We describe clinical outcomes of 13 patients with advanced HIV (CD4 <200 cells/mm3), severe mpox, and multi-organ involvement. Despite extended tecovirimat courses and additional agents, including vaccinia immune globulin, cidofovir, and brincidofovir, this group experienced prolonged hospitalizations and high mortality.
Full citation:
Garcia EA, Foote MMK, McPherson TD..., Mgbako O, ...Wong M (2024). Severe mpox among people living with advanced HIV receiving prolonged tecovirimat in New York City
Open Forum Infectious Diseases, 11 (6), ofae294. doi: 10.1093/ofid/ofae294. PMCID: PMC11168585.